SCHEMBL5485083

SCHEMBL5485083

O=C(O)c1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MAP2K4 P45985 1/20 0.43
RXRA P19793 2/20 0.42
RARB P10826 1/20 0.42
RARG P13631 1/20 0.42
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
MAP4K4 O95819 1/20 0.40
CAMKK2 Q96RR4 2/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
AXL P30530 2/20 0.39
SGK1 O00141 1/20 0.39
TTR P02766 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436864 0.87 MKNK1 (0.47) NPC1RAB9AMAP2K4KDM4EALDH1A1
SCHEMBL29034386 0.84 DCUN1D1 (0.45) NPC1RAB9AALDH1A1HPGDMAP4K4
SCHEMBL2819906 0.84 KDM4E (0.50) NPC1RAB9AMAP2K4KDM4EKMT2A
SCHEMBL3397570 0.84 DCUN1D1 (0.47) NPC1RAB9AALDH1A1HPGDMAP4K4
SCHEMBL29499607 0.84 DCUN1D1 (0.47) NPC1RAB9AALDH1A1HPGDMAP4K4
SCHEMBL9389770 0.83 MAPT (0.54) KDM4EKMT2AALDH1A1
SCHEMBL28489775 0.82 KDM4E (0.49) NPC1RAB9AMAP2K4KDM4EKMT2A
SCHEMBL9155822 0.81 ABL1 (0.47) NPC1RAB9AKMT2A
SCHEMBL7399803 0.78 DCUN1D1 (0.36) KDM4EKMT2AALDH1A1
SCHEMBL1773521 0.78 FYN (0.39) MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070072923-A1 Process for producing 2'-(1h-tetrazol-5-yl)biphenyl-4-carbaldehyde SUMITOMO CHEMICAL COMPANY, LIMITED 2007-03-29 US claimed
EP-1666471-A1 PROCESS FOR PRODUCING 2' -(1H-TETRAZOL-5-YL)-BIPHENYL-4-CARBALDEHYDE Sumitomo Chemical Company, Limited (JP) 2006-06-07 EP claimed
US-20070072923-A1 Process for producing 2'-(1h-tetrazol-5-yl)biphenyl-4-carbaldehyde SUMITOMO CHEMICAL COMPANY, LIMITED 2007-03-29 US disclosed
EP-1666471-A1 PROCESS FOR PRODUCING 2' -(1H-TETRAZOL-5-YL)-BIPHENYL-4-CARBALDEHYDE Sumitomo Chemical Company, Limited (JP) 2006-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072923-A1 Process for producing 2'-(1h-tetrazol-5-yl)biphenyl-4-carbaldehyde TH, CYP4B1, ABL1 NPC1 4000/4885RAB9A 3548/4885MAP2K4 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.